|
Market Closed -
Börse Stuttgart
23:55:37 09/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 35.60 EUR | -0.56% |
|
+0.56% | -12.75% |
| 10-07 | Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule | MT |
| 10-07 | European Equities Traded in US as ADRs Fall in Wednesday Trading | MT |
| Market Cap | 85.69B 95.94B 79.71B 72.5B 137B 9,285B 137B 959B 376B 4,734B 360B 352B 15,192B | P/E 2026 * |
11.6x | P/E 2027 * | 10x |
|---|---|---|---|---|---|
| Enterprise Value | 97.02B 109B 90.25B 82.09B 155B 10,514B 156B 1,086B 426B 5,360B 408B 399B 17,201B | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.86x |
| Free-Float |
88.34% | Yield 2026 * |
5.95% | Yield 2027 * | 6.3% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SNY | Delayed | |
CBOE
| SNY | Real-time | |
|
London S.E.
| 0A2V | Delayed | |
|
Mexican S.E.
| SNY N | End-of-day quote | |
|
Tradegate
| SNW2 | Real-time | |
|
Boerse Muenchen
| SNW2 | Real-time | |
|
Deutsche Boerse AG
| SNW2 | Delayed | |
|
Börse Stuttgart
| SNW2 | Delayed |
Last Transcript: Sanofi
| 1 week | +0.56% | ||
| Current month | -2.20% | ||
| 1 month | -3.26% | ||
| 3 months | -7.29% | ||
| 6 months | -11.44% | ||
| Current year | -12.75% |
| 1 week | 34.8 |  | 35.8 |
| 1 month | 34.6 | | 37.6 |
| 3 years | 34.6 | | 55 |
| 5 years | 34.6 | | 55 |
| 10 years | 30.6 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | +0.56% | -15.64% | -29.50% | 95.94B | |
| +0.83% | +3.19% | +37.87% | +106.25% | 1,051B | |
| +1.93% | +2.11% | +36.82% | +64.90% | 630B | |
| +1.49% | +5.19% | +19.84% | +85.41% | 489B | |
| +2.26% | +0.90% | +66.40% | +39.33% | 359B | |
| +1.45% | +3.50% | +21.87% | +42.64% | 344B | |
| +1.17% | +2.37% | +11.71% | +35.14% | 272B | |
| +0.89% | +1.08% | -7.28% | +10.52% | 246B | |
| +1.82% | +2.94% | +40.43% | +52.78% | 224B | |
| +2.77% | +4.44% | +29.49% | +101.40% | 187B | |
| Average | +1.50% | +2.53% | +24.15% | +50.89% | 422.63B | |
| Weighted average by Cap. | +1.20% | +2.44% | +30.41% | +67.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.35B 53.01B 44.04B 40.06B 75.64B 5,131B 75.97B 530B 208B 2,616B 199B 195B 8,394B | 50.47B 56.51B 46.95B 42.7B 80.62B 5,469B 80.97B 565B 221B 2,788B 212B 208B 8,947B |
| Net income | 7.3B 8.17B 6.79B 6.17B 11.66B 791B 11.71B 81.71B 32.01B 403B 30.68B 30.01B 1,294B | 8.81B 9.87B 8.2B 7.46B 14.08B 955B 14.14B 98.68B 38.66B 487B 37.06B 36.25B 1,563B |
| Net Debt | 11.34B 12.69B 10.55B 9.59B 18.11B 1,228B 18.19B 127B 49.73B 626B 47.66B 46.62B 2,010B | 8B 8.96B 7.45B 6.77B 12.79B 867B 12.84B 89.61B 35.11B 442B 33.65B 32.92B 1,419B |
| Date | Price | Change |
|---|---|---|
| 09/10/26 | €35.60 | -0.56% |
| 08/10/26 | €35.80 | 0.00% |
| 07/10/26 | €35.80 | +2.29% |
| 06/10/26 | €35.00 | -0.57% |
| 05/10/26 | €35.20 | -0.56% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
Select your edition
All financial news and data tailored to specific country editions
